Stericycle (NASDAQ:SRCL) Updates FY 2024 Earnings Guidance

Stericycle (NASDAQ:SRCL) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 2.200-2.500 for the period, compared to the consensus earnings per share estimate of 2.330. The company issued revenue guidance of -.

Stericycle Trading Down 0.4 %

Shares of SRCL stock traded down $0.20 during mid-day trading on Friday, reaching $46.31. The stock had a trading volume of 802,019 shares, compared to its average volume of 467,025. The stock’s 50-day moving average price is $51.35 and its two-hundred day moving average price is $48.17. Stericycle has a 52-week low of $37.78 and a 52-week high of $57.06. The firm has a market capitalization of $4.30 billion, a PE ratio of -192.95, a price-to-earnings-growth ratio of 2.68 and a beta of 1.09. The company has a current ratio of 0.94, a quick ratio of 0.94 and a debt-to-equity ratio of 0.51.

Stericycle (NASDAQ:SRCL) last announced its quarterly earnings results on Thursday, April 25th. The business services provider reported $0.57 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.03. Stericycle had a negative net margin of 0.80% and a positive return on equity of 7.06%. The company had revenue of $664.90 million for the quarter, compared to analysts’ expectations of $676.42 million. During the same quarter in the previous year, the company earned $0.49 earnings per share. Stericycle’s quarterly revenue was down 2.8% on a year-over-year basis. Equities analysts expect that Stericycle will post 2.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

SRCL has been the topic of a number of recent research reports. Truist Financial upped their price objective on shares of Stericycle from $50.00 to $57.00 and gave the stock a hold rating in a report on Thursday, February 29th. Royal Bank of Canada reiterated an outperform rating and issued a $69.00 target price on shares of Stericycle in a research note on Thursday, March 7th. Wells Fargo & Company upped their target price on shares of Stericycle from $40.00 to $48.00 and gave the stock an underweight rating in a research note on Friday, March 1st. Stifel Nicolaus upped their target price on shares of Stericycle from $70.00 to $75.00 and gave the stock a buy rating in a research note on Thursday, February 29th. Finally, StockNews.com downgraded shares of Stericycle from a buy rating to a hold rating in a research note on Tuesday, April 2nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of Hold and an average target price of $60.80.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.